Published in Am J Hum Genet on September 01, 1993
Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet (2002) 2.47
Detecting disease-predisposing variants: the haplotype method. Am J Hum Genet (1997) 2.33
Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res (1999) 1.63
Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet (1996) 1.23
Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet (1995) 1.19
Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet (2002) 1.11
HLA-linked rheumatoid arthritis. Am J Hum Genet (1994) 1.03
Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am J Hum Genet (1996) 0.97
Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci U S A (1996) 0.95
Reproductive failure and the major histocompatibility complex. Am J Hum Genet (1995) 0.90
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum (1987) 14.21
The affected-pedigree-member method of linkage analysis. Am J Hum Genet (1988) 13.67
Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med (1978) 7.97
HLA and insulin gene associations with IDDM. Genet Epidemiol (1989) 6.53
A simple and efficient non-organic procedure for the isolation of genomic DNA from blood. Nucleic Acids Res (1989) 5.27
Genes predisposing to IDDM in multiplex families. Genet Epidemiol (1989) 2.92
HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A (1989) 2.60
A new method to test genetic models in HLA associated diseases: the MASC method. Ann Hum Genet (1988) 2.03
HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet (1992) 2.03
Investigation of the mode of inheritance of the HLA associated diseases by the method of antigen genotype frequencies among diseased individuals. Tissue Antigens (1983) 1.97
HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum (1990) 1.90
HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis (1986) 1.66
Investigating the HLA component in rheumatoid arthritis: an additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol (1991) 1.60
Dw14(DRB1*0404) is a Dw4-dependent risk factor for rheumatoid arthritis. Rethinking the "shared epitope" hypothesis. Tissue Antigens (1991) 1.50
Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. Arthritis Rheum (1991) 1.48
Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol (1982) 1.28
HLA DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis (1981) 1.17
Genetics of rheumatoid arthritis. Tissue Antigens (1986) 1.13
Dw subtypes of DR4 in rheumatoid arthritis: evidence for a preferential association with Dw4. Hum Immunol (1986) 1.12
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens (1990) 1.01
HLA-DR antigens and rheumatoid arthritis in black South Africans: a study of ethnic groups. Tissue Antigens (1992) 0.85
Analysis of genetic susceptibility to familial rheumatoid arthritis. Dis Markers (1986) 0.83
Effects of misspecifying genetic parameters in lod score analysis. Biometrics (1986) 6.36
Genetic analysis of IDDM: summary of GAW5 IDDM results. Genet Epidemiol (1989) 5.06
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis (2004) 3.64
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis (2003) 3.33
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet (1999) 3.14
Bias of the estimated recombination fraction and lod score due to an association between a disease gene and a marker gene. Ann Hum Genet (1982) 3.12
Linkage detection by the Affected-Pedigree-Member method: what is really tested? Genet Epidemiol (1993) 2.88
A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet (1994) 2.71
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis (2000) 2.34
Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer (1981) 2.23
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Focal myositis: a localized form of polymyositis? J Rheumatol (1993) 2.05
A new method to test genetic models in HLA associated diseases: the MASC method. Ann Hum Genet (1988) 2.03
Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum (2001) 2.00
Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis Rheum (2006) 1.96
Statistical properties of the allelic and genotypic transmission/disequilibrium test for multiallelic markers. Genet Epidemiol (1995) 1.92
Endocarditis associated with ANCA. Clin Exp Rheumatol (1994) 1.85
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis (2004) 1.76
Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet (1993) 1.74
Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease. Am J Hum Genet (1992) 1.71
Conclusions of segregation analysis for family data generated under two-locus models. Am J Hum Genet (1993) 1.67
Search for multifactorial disease susceptibility genes in founder populations. Ann Hum Genet (2000) 1.66
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum (1993) 1.63
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
Inflammatory joint disease after immunizations. A report of two cases. Rev Rhum Engl Ed (1997) 1.61
Posterior probability of linkage and maximal lod score. Ann Hum Genet (1995) 1.58
HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens (2004) 1.56
Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum (1990) 1.51
HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides. Immunogenetics (1999) 1.49
Two-disease locus model: sib pair method using information on both HLA and Gm. Genet Epidemiol (1986) 1.49
Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis. Arthritis Rheum (2002) 1.48
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47
Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol (1995) 1.46
Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol (1998) 1.45
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis (1999) 1.44
On the use of chi 2 tests for nested categorized data. Ann Hum Genet (1990) 1.44
Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum (1997) 1.44
Immunological aspects of psoriasis. II. Dissociated impairment of thymus-dependent lymphocytes. Br J Dermatol (1976) 1.44
Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. J Rheumatol (1997) 1.43
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun (2008) 1.43
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study. Ann Rheum Dis (2006) 1.42
A gene for Meckel syndrome maps to chromosome 11q13. Am J Hum Genet (1998) 1.42
Application of the lod score method to detection of linkage between HLA and juvenile insulin-dependent diabetes. Clin Genet (1980) 1.41
Interactive effect of two candidate genes in a disease: extension of the marker-association-segregation chi(2) method. Am J Hum Genet (1994) 1.41
Strategy for detecting susceptibility genes with weak or no marginal effect. Hum Hered (2007) 1.41
Manic depressive illness is linked to factor IX in a French pedigree. Ann Genet (1992) 1.40
[Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration]. Nephrologie (2000) 1.40
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS (2001) 1.38
Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma. J Clin Invest (1991) 1.38
Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol (1989) 1.33
Assessing the effect of multiple linkage tests in complex diseases. Genet Epidemiol (1990) 1.33
Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Ann Rheum Dis (2003) 1.32
Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol (1998) 1.29
Optimization of genome search strategies for homozygosity mapping: influence of marker spacing on power and threshold criteria for identification of candidate regions. Ann Hum Genet (1998) 1.29
Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis (2004) 1.29
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol (1999) 1.27
Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients. Blood (1984) 1.26
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet (1996) 1.26
The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group. Arthritis Rheum (1997) 1.26
Linkage analysis in spinal muscular atrophy, by six closely flanking markers on chromosome 5. Am J Hum Genet (1991) 1.26
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25
Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol (1999) 1.25
Use of closely related affected individuals for the genetic study of complex diseases in founder populations. Am J Hum Genet (2000) 1.23
Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis (1996) 1.23
Acute osteoporotic vertebral collapse: open study on percutaneous injection of acrylic surgical cement in 20 patients. AJR Am J Roentgenol (1999) 1.23
The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 1.21
Improved use of SNP information to detect the role of genes. Genet Epidemiol (2003) 1.20
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis (2004) 1.18
Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol (1993) 1.17
HL-A antigens in rheumatoid arthritis. Vox Sang (1972) 1.17
Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the 'Orencia and Rheumatoid Arthritis' registry. Ann Rheum Dis (2012) 1.16
Radiological damage in patients with rheumatoid arthritis on sustained remission. Ann Rheum Dis (2006) 1.16
Juvenile insulin-dependent diabetes: a possible susceptibility gene in interaction with HLA. Ann Hum Genet (1981) 1.15
Genome search in celiac disease. Am J Hum Genet (1998) 1.14